Results 291 to 300 of about 167,089 (310)
Some of the next articles are maybe not open access.

Current and emerging medications for the treatment of leishmaniasis

Expert Opinion on Pharmacotherapy, 2019
Introduction: Leishmaniasis is a vector-borne neglected tropical disease which manifests as visceral leishmaniasis (VL), cutaneous leishmaniasis (CL), and mucocutaneous leishmaniasis (MCL).
J. Chakravarty, S. Sundar
semanticscholar   +1 more source

Leishmaniasis in Turkey

Acta Tropica, 2002
Leishmaniases are widespread in most countries in the Mediterranean basin, including Turkey. Two forms are observed in Turkey; Leishmania infantum is responsible from visceral leishmaniasis (VL), and L. tropica causes cutaneous leishmaniasis (CL). Phlebotomus sergenti, P. papatasi, P. major and P. syriacus are considered to be the probable vectors, and
Balcioglu, IC   +4 more
openaire   +3 more sources

Leishmaniasis

Journal of Infection, 2014
Leishmaniasis remains an important neglected tropical infection that affects children more than adults. Geographical variation exists in the distribution of the various Leishmania species. Although the majority of the disease burden is found in poor countries, leishmaniasis is also endemic in several countries within Southern Europe.
openaire   +2 more sources

Leishmaniasis and poverty

Trends in Parasitology, 2006
Leishmaniasis, a neglected tropical disease, has strong but complex links with poverty. The burden of leishmaniasis falls disproportionately on the poorest segments of the global population. Within endemic areas, increased infection risk is mediated through poor housing conditions and environmental sanitation, lack of personal protective measures and ...
Jorge Alvar, Caryn Bern, Sergio Yactayo
openaire   +3 more sources

Immunology of leishmaniasis

Current Opinion in Immunology, 1992
Resolution of leishmanial infections requires the expansion of specific type 1 T helper cells that secrete or express on their membrane lymphokines capable of activating macrophages that contain these parasites to a microbicidal state. Specific CD8+ T cells, which are triggered during infection, also appear to play a role in protective immunity ...
Jacques A. Louis   +2 more
openaire   +3 more sources

Leishmaniasis: where are we and where are we heading?

Parasitology Research, 2021
S. Sasidharan, Prakash Saudagar
semanticscholar   +1 more source

The Immunobiology of Leishmaniasis

Clinical Infectious Diseases, 1983
Members of the genus Leishmania are important intracellular pathogens that produce either cutaneous, mucocutaneous, or visceral disease in many areas of the world. In humans as well as in other mammals, the parasite is inoculated through the skin as a flagellated, extracellular promastigote by its arthropod vector, the sandfly.
Richard D. Pearson   +3 more
openaire   +3 more sources

Recent advances and new strategies on leishmaniasis treatment

Applied Microbiology and Biotechnology, 2020
B. Roatt   +5 more
semanticscholar   +1 more source

Leishmaniasis: current situation and new perspectives.

Comparative Immunology, Microbiology & Infectious Diseases, 2004
P. Desjeux
semanticscholar   +1 more source

Leishmaniasis

2000
M. Onder, M. Ali Gurer
openaire   +1 more source

Home - About - Disclaimer - Privacy